Switzerland· 69007001
Tranexamic OrPha 500 mg/5 ml, Injektionslösung
A tranexamic acid product containing acidum tranexamicum, registered in Switzerland by OrPha Swiss GmbH and dispensed under Swissmedic category B. The same ATC class is registered in 15 of our 19 countries.
Checked against Swissmedic (Switzerland) on
Informational only — not a medical device.
Where it is registered
Tranexamic acid is registered in 15 of 19 countries.
Countries holding a registration under ATC B02AA02 (tranexamic acid), each read from that country’s own register.
- This record: Switzerland, from Swissmedic (Switzerland)
- 9 of them publish a price we can compare per daily dose
Tranexamic acid · ATC B02AA02
15 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of tranexamic acid costs, country by country.
Normalised to the WHO defined daily dose (2 g), the median price runs from $1.69 in Italy to $34.44 in Switzerland — a ×20 gap.
- Switzerland: $34.44 per daily dose (median across products in the class)
- Public list prices, converted to USD at the rate date shown
Tranexamic acid · price per daily dose (2 g)
USD · FX 28 Sept 2026
- CH Switzerland$34.44
- IT Italy$1.69
The record
At a glance
Swissmedic (Switzerland)- Active substance
- acidum tranexamicum
- Manufacturer
- OrPha Swiss GmbH
- Country
- Switzerland (CH)
- ATC code
- B02AA02
- ATC class
- Tranexamic acid
- Defined daily dose
- 2 g, O
- Swissmedic category
- B
- Reimbursed
- No
- Source register
- Swissmedic (Switzerland)
- Last checked
- September 12, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
45 interactions on record for tranexamic acid.
Graded by severity as the source publishes them — 36 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Tranexamic acid · interactions on record
45 records
- 36 severe
- 8 moderate
- 1 minor
Most severe, free to view
- Faktor VIII-Inhibitor Bypass Aktivität - FEIBAB02BD03severe
- EstradiolD11AX34severe
- IUP aus Plastik mit GestagenG02BA03severe
- Levonorgestrel and ethinylestradiolG03AA07severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Tranexamic acid in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaEXACYLCHEPLAPHARM Arzneimittel GmbH, Greifswald
- PolandExacylCHEPLAPHARM Arzneimittel GmbH
- BelgiumExacyl 500 mg/5 mlCheplapharm Arzneimittel
- SwedenMedsamic 100 mg/ml Injektionsvätska, lösningMedochemie Ltd
- SpainACIDO TRANEXAMICO AUROVITAS 100 MG/ML SOLUCION INYECTABLE EFGAurovitas Spain, S.A.U.
- ItalyACIDO TRANEXAMICO AUROBINDOEUGIA PHARMA (MALTA) LIMITED
- FinlandCyklokapronPharmacia Oy
- NorwayPilexamPilum Pharma A/S
Authorised across Europe · EMA
The same active substance is authorised in 30 EEA countries. Names it is sold under:
- Austria · Cyklokapron, Tranexamsäure Baxter
- Belgium · Acide Tranexamique Kabi, Cyklokapron
- Bulgaria · Медокапрон, Т-Капрон
- Cyprus · Azeptil, Medsamic
- Czechia · Exacyl, Tranexamic Acid Accord
- Germany · Cyklokapron, Cyklokapron-Injektionslösung
- Denmark · Cyklokapron, Cyklonova
- Estonia · Cyklokapron, Medsamic
- Spain · Ácido Tranexámico Baxter, Ácido Tranexámico Viatris
- Finland · Caprilon, Cyklokapron
- France · Acide Tranexamique Accord, Acide Tranexamique Aguettant
- United Kingdom (Northern Ireland) · Cyklo-F, Cyklokapron
- Greece · Tranexamic Acid /Kabi, Tranexamic Acid Baxter
- Croatia · Medsamic, Trenolk
- Hungary · Exacyl, Nimra
- Ireland · Cyklokapron, Tranexamic Acid Accord Healthcare Ireland
- Iceland · Cyklokapron, Tranexamsyre Pfizer
- Italy · Acido Tranexamico Adamed, Acido Tranexamico Aurobindo
- Lithuania · Haixa, Tranexamic Acid Baxter
- Luxembourg · Exacyl, Tranexamsäure Dr. Eberth
- Latvia · Cyklokapron, Haixa
- Malta · Azeptil, Medsamic
- Netherlands · Cyklokapron, Nexag
- Norway · Cyklokapron, Pilexam
- Poland · Deporium, Deporium Comfort
- Portugal · Ácido Tranexâmico A.Forall, Ácido Tranexâmico Accord
- Romania · Acid Tranexamic Kabi, Medsamic
- Sweden · Cyklo-F, Cyklokapron
- Slovenia · Medsamic, Trenolk
- Slovakia · Medsamic, Tranexamic Acid Kabi
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swissmedic (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b6946109-85fc-4681-afba-1f59ff0a2177 GET /v1/drugs/b6946109-85fc-4681-afba-1f59ff0a2177?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "swissmedic_auth",
"heilmittelcode": "Synthetika"
}See everything about tranexamic acid.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.